HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
- 31 May 1998
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 138 (1) , 11-24
- https://doi.org/10.1016/s0021-9150(98)00014-8
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- The natural history of asymptomatic carotid artery diseaseJournal of Vascular Surgery, 1993
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Outcome in Patients with Asymptomatic Neck BruitsNew England Journal of Medicine, 1986
- Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland.Stroke, 1982
- Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart Study.Stroke, 1980
- The Treatment of Cerebrovascular Disease With ClofibrateStroke, 1973
- Controlled trial of clofibrate in cerebral vascular diseaseAtherosclerosis, 1972